GSK

GSK plc

NYSE · Healthcare
—
(—)
GSK News1 articles
GSK Gains EU Approval for Nucala in COPD, Stock Momentum in Focus
GSK shares rose after EU regulators approved expanded use of Nucala for chronic obstructive pulmonary disease. The stock has surged 17% this week and nearly 49% over the past year.
Regulation 20h ago